Untreated chronic pain patients on waitlists for psychological care show no significant symptom change over short periods, according to a recent meta-analysis.

Recommendations from the American College of Obstetricians and Gynecologists outline a range of pain management options for routine procedures. By Alisha Haridasani Gupta A national organization that ...

On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe pain. The prescription pills, sold under the brand name Journavx and made by ...